As of Jul 29
| -0.10 / -0.87%|
The 5 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 20.00 and a low estimate of 13.00. The median estimate represents a +40.35% increase from the last price of 11.40.
The current consensus among 5 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.